NCT05651152View on ClinicalTrials.gov

A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
Healthy Participants
Interventions
DRUG

JZP441

Nighttime oral dose

DRUG

Placebo

Nighttime oral dose

Trial Locations (2)

10016

Clinical Site 2, New York

07724

Clinical Site 1, Eatontown

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY